top of page
SEAVI Advent Announces Investment in Leading TCM Provider, Shuang Yi Pharmaceutical and Biotech Holdings
May 2026 SEAVI Advent Private Equity today announced that its latest fund, SEAVI Advent VIII Fund has completed an investment in Shuang Yi Pharmaceutical and Biotech Holdings Ltd (the "Company"). The Company is a national high-tech enterprise specializing in the R&D, biotechnological extraction, standardization, and commercialization of Zhuang traditional medicines and botanical drug candidates. The Company has repeatedly been recognized as a National High-tech Enterprise and
May 18
SEAVI Advent Private Equity announces the 1st close of its latest fund - SEAVI Advent Equity VIII
May 2026 SEAVI Advent Private Equity has announced the 1st closing of its latest fund - SEAVI Advent Equity VIII, consisting of 2 sub-funds under its SEAVI Advent VCC. The Fund's initial close was raised from high net-worth individuals, corporate institutions and family offices. SEAVI Advent's partners also made a strong commitment of US$3 million in the Fund. SEAVI Advent will continue to reach out to existing and new investors, mostly based in Singapore, Hong Kong, Mainland
May 18
SEAVI Advent Private Equity announces that it has fully exited its holdings in Xuan Wu Cloud Technology Holding
SEAVI Advent Private Equity today announced that it has fully exited its holdings in Xuan Wu Cloud Technology Holding (Stock Code: 02392.HK), a leading intelligent Customer Relationship Management SaaS company focused on serving mid and large-cap enterprise customers in the People’s Republic of China. SEAVI Advent’s investment in Xuan Wu during the Covid-19 period supported the company’s capital markets strategy and helped in its international expansion into Southeast Asia,
May 14
SEAVI Advent Announces Paring Down of its Investment in Huitongda Network Co., Ltd
10 February 2026 SEAVI Advent Private Equity today announced that it has pared down its holdings in Huitongda Network Co., Ltd (Stock Code: 9878.HK) (the “Company”) to residual value so as to address overhang issues of the Company. While SEAVI has realised a portion of its position, it retains a sizable stake in the Company, reflecting a continued commitment to capturing the Company’s full intrinsic value as capital market conditions evolve. The Company has demonstrated robus
Feb 11
SEAVI Advent announces partial divestment of its shareholding in Evergreen Products Group Limited
SEAVI Advent Private Equity today announced that its sixth fund, SEAVI Advent Equity VI, has completed a partial divestment of its stake...
Jan 14, 2025
SEAVI Advent announces complete divestment of its shareholding in Yuanhang Precision Alloy
7 March 2023 SEAVI Advent Private Equity today announced that its sixth fund, SEAVI Advent Equity VI has fully divested its remaining...
Mar 12, 2024
SEAVI Advent completes investment in Jianzhi Education
8 February 2023 SEAVI Advent Private Equity today announced that its sixth fund, SEAVI Advent Equity VI has successfully completed its...
Mar 12, 2024
SEAVI Advent Announces Investment in Leading CRM SaaS Provider, Xuan Wu Cloud Technology
August 2022 SEAVI Advent Private Equity today announced that its latest fund, SEAVI Advent Equity VII (Special Situation) Fund I has...
Aug 11, 2022
bottom of page